Fernando Andrés-Pretel

Fernando Andrés-Pretel

Auto-generated profile, based on publicly available information

Fernando Andrés-Pretel

University Hospital Complex of Albacete, C/ Hermanos Falcó n°37. 02006 Albacete. Spain

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Molecular Cancer Therapeutics
Verified
Journal Article
Open access
PDF file
AAAna Alcaraz-Sanabria
Ana Alcaraz-Sanabria
CNCristina Nieto
Cristina Nieto
VCVerónica Corrales-Sánchez
Verónica Corrales-Sánchez
LSLeticia Serrano-Oviedo
Leticia Serrano-Oviedo
FAFernando Andrés-Pretel
Fernando Andrés-Pretel
AOAlberto Ocana
Alberto Ocana
Ovarian cancer is characterized by frequent mutations at TP53. These tumors also harbor germline mutations at homologous recombination repair genes, so they rely on DNA-damage checkpoint proteins, like the checkpoint kinase 1 (CHEK1) to induce G2 arrest. In our study, by using an in silico approach, we identified a synthetic lethality interaction between CHEK1 and mitotic aurora kinase A (AURKA) inhibitors. Gene expression analyses were used for the identification of relevant biological functions. OVCAR3, OVCAR8, IGROV1, and SKOV3 were used for proliferation studies. Alisertib was tested as AURKA inhibitor and LY2603618 as CHEK1 inhibitor. Analyses of cell cycle and intracellular mediators were performed by flow cytometry and Western blot analysis. Impact on stem cell properties was evaluated by flow cytometry analysis of surface markers and sphere formation assays. Gene expression analyses followed by functional annotation identified a series of deregulated genes that belonged to cell cycle, including AURKA/B, TTK kinase, and CHEK1. AURKA and CHEK1 were amplified in 8.7% and 3.9% of ovarian cancers, respectively. AURKA and CHEK1 inhibitors showed a synergistic interaction in different cellular models. Combination of alisertib and LY2603618 triggered apoptosis, reduced the stem cell population, and increased the effect of taxanes and platinum compounds. Finally, expression of AURKA and CHEK1 was linked with detrimental outcome in patients. Our data describe a synthetic lethality interaction between CHEK1 and AURKA inhibitors with potential translation to the clinical setting. Mol Cancer Ther; 16(11); 2552–62. ©2017 AACR.

12 January 2018 in Breast Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
MNMiriam Nuncia-Cantarero
Miriam Nuncia-Cantarero
SMSandra Martinez-Canales
Sandra Martinez-Canales
FAFernando Andrés-Pretel
Fernando Andrés-Pretel
Gabriel SantpereGabriel Santpere
Gabriel Santpere
AOAlberto Ocana
Alberto Ocana
EGEva Galan-Moya
Eva Galan-Moya
Purpose Although obesity is a risk factor for breast cancer, little effort has been made in the identification of druggable molecular alterations in obese–breast cancer patients. Tumors are controlled by their surrounding microenvironment, in which the adipose tissue is a main component. In this work, we intended to describe molecular alterations at a transcriptomic and protein–protein interaction (PPI) level between obese and non-obese patients. Methods and results Gene expression data of 269 primary breast tumors were compared between normal-weight (BMI < 25, n = 130) and obese (IMC > 30, n = 139) patients. No significant differences were found for the global breast cancer population. However, within the luminal A subtype, upregulation of 81 genes was observed in the obese group (FC ≥ 1.4). Next, we explored the association of these genes with patient outcome, observing that 39 were linked with detrimental outcome. Their PPI map formed highly compact cluster and functional annotation analyses showed that cell cycle, cell proliferation, cell differentiation, and cellular response to extracellular stimuli were the more altered functions. Combined analyses of genes within the described functions are correlated with poor outcome. PPI network analyses for each function were to search for druggable opportunities. We identified 16 potentially druggable candidates. Among them, NEK2, BIRC5, and TOP2A were also found to be amplified in breast cancer, suggesting that they could act as strategic players in the obese-deregulated transcriptome. Conclusion In summary, our in silico analysis describes molecular alterations of luminal A tumors and proposes a druggable PPI network in obese patients with potential for translation to the clinical practice.

1 February 2016 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
AOAlberto Ocana
Alberto Ocana
LDLaura Díez-González
Laura Díez-González
Damián García-OlmoDamián García-Olmo
Damián García-Olmo
ATArnoud J. Templeton
Arnoud J. Templeton
FVFrancisco Vera-Badillo
Francisco Vera-Badillo
EAEitan Amir
Eitan Amir
Background: The ability to undertake molecular analysis to inform on prognosis and predictors of response to therapy is limited by accessibility of tissue. Measurement of total circulating free DNA (cfDNA) or circulating tumor DNA (ctDNA) in peripheral blood may allow easier access to tumor material and help to predict clinical outcomes. Methods: A systematic review of electronic databases identified publications exploring the association between cfDNA or ctDNA and overall survival (OS) in solid tumors. HRs for OS were extracted from multivariable analyses and included in a meta-analysis. Pooled HRs were computed and weighted using generic inverse variance and random-effect modeling. For studies not reporting multivariable analyses, univariable ORs were estimated from Kaplan–Meier curves for OS at 1 and 3 years. Results: Thirty-nine studies comprising 4,052 patients were included in the analysis. Detection of ctDNA was associated with a significantly worse OS in multivariable analyses [HR, 2.70; 95% confidence interval (CI), 2.02–3.61; P < 0.001). Similar results were observed in the univariable analyses at 3 and 1 year (OR, 4.83; 95% CI, 3.20–7.28; P < 0.001).There was also a statistically significant association between high total cfDNA and worse OS for studies reporting multivariable and univariate data at 3 years (HR, 1.91; 95% CI, 1.59–2.29; P < 0.001 and OR, 2.82; 95% CI, 1.93–4.13; P < 0.001, respectively). Conclusions: High levels of total cfDNA and presence of ctDNA are associated with worse survival in solid tumors. Impact: Circulating DNA is associated with worse outcome in solid tumors. Cancer Epidemiol Biomarkers Prev; 25(2); 399–406. ©2015 AACR.

1 November 2012 in Gaceta Sanitaria
Verified
Journal Article
Open access
FAFernando Andrés-Pretel
Fernando Andrés-Pretel
BBBeatriz Navarro Bravo
Beatriz Navarro Bravo
IMIgnacio Párraga Martínez
Ignacio Párraga Martínez
MGM.A Antonia de la Torre García
M.A Antonia de la Torre García
MVM.A Dolores Jiménez del Val
M.A Dolores Jiménez del Val
JHJesús López-Torres Hidalgo
Jesús López-Torres Hidalgo
ResumenObjetivosEl objetivo de este estudio es determinar los conocimientos y las actitudes que presentan las personas mayores hacia el documento de voluntades anticipadas.MétodosEstudio descriptivo transversal, realizado en atención primaria en las provincias de Albacete y Guadalajara (n = 464).ResultadosEl 86,2% (intervalo de confianza del 95% [IC95%]: 83,0-89,5) de los sujetos no conocía el documento y solo el 3,4% (IC95%: 1,7-5,3) lo había formalizado. El 76,7% (IC95%: 72,8-80,7) consideró que la existencia del documento es conveniente. Las variables asociadas mediante regresión logística con una mejor actitud hacia las voluntades anticipadas fueron el nivel de instrucción (odds ratio [OR] = 4,7; IC95%: 2,6-8,4) y haber vivido una experiencia en que el documento hubiese ayudado (OR = 1,9; IC95%: 1,1-3,4).ConclusionesLos mayores muestran una actitud positiva hacia las voluntades anticipadas, pero la proporción de personas que conocen el documento es baja.AbstractObjectivesThe aim of this study was to determine seniors’ knowledge of and attitudes toward advance directive documents.MethodsWe carried out a cross-sectional descriptive study in a primary care setting in the provinces of Albacete and Guadalajara, Spain (n = 464).ResultsA total of 86.2% (95% CI: 83.0-89.5) of the participants were unaware of advance directive documents and only 3.4% (95% CI: 1.7-5.3) had formalized one. These documents were positively viewed by 76.7% of the participants (95% CI: 72.8-80.7). The variables associated with positive attitudes toward advance directives in logistic regression were educational level (OR = 4.7; 95% CI: 2.6-8.4) and experience of a situation in which such a document would have helped (OR = 1.7; 95% CI: 1.1-3.4).ConclusionsSeniors had positive attitudes toward advance directives, but the proportion of persons aware of these documents was low

1 January 2011 in Atencion Primaria
Verified
Journal Article
Closed access
BBBeatriz Navarro Bravo
Beatriz Navarro Bravo
MGMargarita Sánchez García
Margarita Sánchez García
FPFernando Andrés Pretel
Fernando Andrés Pretel
ICInés Juárez Casalengua
Inés Juárez Casalengua
RDRosario Cerdá Díaz
Rosario Cerdá Díaz
JHJesús D. López-Torres Hidalgo
Jesús D. López-Torres Hidalgo

23 December 2011 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
JHJesús López‐Torres Hidalgo
Jesús López‐Torres Hidalgo
BBBeatriz Navarro Bravo
Beatriz Navarro Bravo
IMIgnacio Párraga Martínez
Ignacio Párraga Martínez
FPFernando Andrés Pretel
Fernando Andrés Pretel
JLJuan Téllez Lapeira
Juan Téllez Lapeira
CGClotilde Boix Gras
Clotilde Boix Gras